PhoenixBio Co., Ltd. (TYO:6190)

Japan flag Japan · Delayed Price · Currency is JPY
444.00
-2.00 (-0.45%)
Apr 17, 2026, 3:30 PM JST
Market Cap1.81B +19.9%
Revenue (ttm)1.60B +4.4%
Net Income-205.00M
EPS-50.78
Shares Out4.07M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume5,900
Average Volume14,945
Open442.00
Previous Close446.00
Day's Range442.00 - 446.00
52-Week Range315.00 - 724.00
Beta0.36
RSI45.19
Earnings DateMay 15, 2026

About PhoenixBio

PhoenixBio Co., Ltd. provides contract testing services for medical product development in Japan, the United States, and internationally. The company offers PXB-mouse, a chimeric mouse with a humanized liver used in drug development experiments; and PXB-cells, human hepatocytes for in vitro studies and experiments, as well as HBV study services. Its products are used in gene therapeutics, MASH/MAFLD, viral hepatitis, DMPK/toxicity, and custom transplantations applications. The company was founded in 2002 and is headquartered in Higashihiroshima... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 69
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 6190
Full Company Profile

Financial Performance

Financial Statements